4D Molecular Therapeutics

4D Molecular Therapeutics has granted 23,600 RSUs to four new employees under its 2025 Employment Inducement Award Plan. This move reflects the company’s strategy to attract and retain key talent in the competitive biotech sector. These inducement grants, common in the industry, are intended to incentivize new hires and support the advancement of the company’s gene therapy pipeline, including its lead candidate 4D-150.